🇺🇸 FDA
Patent

US 9259453

Use of salmonella flagellin derivative in preparation of drug for preventing and treating inflammatory bowel diseases

granted A61KA61K38/00A61K38/164

Quick answer

US patent 9259453 (Use of salmonella flagellin derivative in preparation of drug for preventing and treating inflammatory bowel diseases) held by Institute of Radiation Medicine, Academy of Military Medical Sciences, People's Liberation Army of China expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Institute of Radiation Medicine, Academy of Military Medical Sciences, People's Liberation Army of China
Grant date
Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/00, A61K38/164, A61K9/2806, A61K9/2893